Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	13.20	27.92	24.66
Graham Fair Price	-10.31	2615.45	2916.06
PEG	175.46	-0.67	0.24
Price/Book	-5.14	0.91	0.96
Price/Cash Flow	-32.63	-118.13	-89.06
Prices/Earnings	29.17	15.49	11.99
Price/Sales	-5.80	1.66	1.76
Price/FCF	-32.63	-118.13	-89.06
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	4.20	0.21	0.20
Operating Margin	-24.98	0.05	0.06
ROA	-24.99	< 0.005	< 0.005
ROE	0.02	0.01	-26.56
ROIC	0.01	0.01	-10.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	0.05	-88.71
Dividends QOQ	13310.17	-1.00	-99.99
EBIT QOQ	0.66	-0.21	-68.18
EPS QOQ	0.49	-0.23	-53.11
FCF QOQ	-1.15	0.25	-78.11
Revenue QOQ	0.08	0.05	-36.15
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	113.69	108.47	-4.59
Days Sales Outstanding (DSO)	76.49	69.30	-9.41
Inventory Turnover	0.79	0.83	4.81
Debt/Capitalization	0.48	0.47	-2.09
Quick Ratio	0.90	0.91	1.52
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	4335.93	4538.08	4.66
Cash	1326.70	1312.27	-1.09
Capex	-200.34	-279.11	-39.31
Free Cash Flow	-46.95	-35.15	25.14
Revenue	2371.28	2499.34	5.40
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.59	1.70	7.04
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.95	11.42	14.74
Naive Interpretation	Member

06 - Financial Health · Weak

Rating